ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
60152 | CDO_ARTBE | D1MF76 | CDO1 {ECO:0000250|UniProtKB:D4AN26} | Cysteine dioxygenase {ECO:0000303|PubMed:21039937}; CDO {ECO:0000303|PubMed:21039937}; 1.13.11.20 {ECO:0000269|PubMed:21039937} | 0 |
60151 | CDO_ARTBC | D4AN26 | CDO1 {ECO:0000303|PubMed:23353986} | Cysteine dioxygenase {ECO:0000303|PubMed:23353986}; CDO {ECO:0000303|PubMed:23353986}; 1.13.11.20 {ECO:0000269|PubMed:21039937} | 9524303 |
60150 | CDO_AJECG | C0NUD7; Q5RLY7 | CDO1 | Cysteine dioxygenase; CDO; 1.13.11.20 | 0 |
60149 | CDON_XENLA | Q90Z04 | cdon | Cell adhesion molecule-related/down-regulated by oncogenes | 373711 |
60148 | CDON_RAT | O35158 | Cdon | Cell adhesion molecule-related/down-regulated by oncogenes | 50938 |
60147 | CDON_MOUSE | E9QKV9; O88971; Q32MD9 | Cdon | Cell adhesion molecule-related/down-regulated by oncogenes | 57810 |
60146 | CDON_HUMAN | O14631; Q4KMG0 | CDON | Cell adhesion molecule-related/down-regulated by oncogenes | 50937 |
60145 | CDOA_BACSU | O32085 | cdoA | Cysteine dioxygenase; CDO; 1.13.11.20 | 938837 |
60144 | CDO1_RAT | P21816; Q6NS32 | Cdo1 | Cysteine dioxygenase type 1; 1.13.11.20 {ECO:0000269|PubMed:9824269}; Cysteine dioxygenase type I; CDO; CDO-I | 81718 |
60143 | CDO1_PONAB | Q5RBQ7 | CDO1 | Cysteine dioxygenase type 1; 1.13.11.20 {ECO:0000250|UniProtKB:Q16878}; Cysteine dioxygenase type I; CDO; CDO-I | 100174398 |
60142 | CDO1_MOUSE | P60334; Q3UED8 | Cdo1 | Cysteine dioxygenase type 1; 1.13.11.20 {ECO:0000269|PubMed:16492780}; Cysteine dioxygenase type I; CDO; CDO-I | 12583 |
60141 | CDO1_HUMAN | B2RAK4; P78513; Q16878; Q6FHZ8; Q8TB64 | CDO1 | Cysteine dioxygenase type 1; 1.13.11.20 {ECO:0000269|PubMed:17135237}; Cysteine dioxygenase type I; CDO; CDO-I | 1036 |
60140 | CDO1_DANRE | Q6NWZ9 | cdo1 | Cysteine dioxygenase type 1; 1.13.11.20 {ECO:0000250|UniProtKB:Q16878}; Cysteine dioxygenase type I; CDO; CDO-I | 393714 |
60139 | CDO1_CAEEL | Q20893 | cdo-1 | Cysteine dioxygenase 1; CDO; 1.13.11.20 | 180434 |
60138 | CDO1_BOVIN | Q3SZU4 | CDO1 | Cysteine dioxygenase type 1; 1.13.11.20 {ECO:0000250|UniProtKB:Q16878}; Cysteine dioxygenase type I; CDO; CDO-I | 514462 |
60137 | CDNG_ROSEK | A0A150XSC5 | cdnG {ECO:0000303|PubMed:32877915} | c-di-GMP synthase {ECO:0000303|PubMed:32877915}; 2.7.7.65 {ECO:0000269|PubMed:32877915}; ReCdnE {ECO:0000303|PubMed:32877915}; ReCdnG {ECO:0000305}; cGAS/DncV-like nucleotidyltransferase; CD-NTase | 0 |
60136 | CDNF_RAT | P0C5I0 | Cdnf | Cerebral dopamine neurotrophic factor; ARMET-like protein 1; Arginine-rich protein mutated in early stage tumors-like 1; Conserved dopamine neurotrophic factor | 361276 |
60135 | CDNF_MOUSE | Q8CC36 | Cdnf | Cerebral dopamine neurotrophic factor; ARMET-like protein 1; Conserved dopamine neurotrophic factor | 227526 |
60134 | CDNF_HUMAN | A2RUU0; B4DVW3; Q49AH0 | CDNF | Cerebral dopamine neurotrophic factor; ARMET-like protein 1; Conserved dopamine neurotrophic factor | 441549 |
60133 | CDNE_RHOMG | G2SLH8 | cdnE {ECO:0000303|PubMed:30787435} | Cyclic UMP-AMP synthase {ECO:0000303|PubMed:30787435}; cUMP-AMP synthase {ECO:0000303|PubMed:30787435}; 2.7.7.- {ECO:0000269|PubMed:30787435}; 3',3'-cUAMP synthase {ECO:0000305|PubMed:30787435}; cGAS/DncV-like nucleotidyltransferase; CD-NTase | 0 |
60132 | CDNE_LACSX | P0DUE3 | cdnE {ECO:0000303|PubMed:32877915} | c-di-GMP synthase {ECO:0000303|PubMed:32877915}; 2.7.7.65 {ECO:0000269|PubMed:32877915}; LbCdnE {ECO:0000303|PubMed:32877915}; cGAS/DncV-like nucleotidyltransferase; CD-NTase | 0 |
60131 | CDNE_FLASX | P0DUE2 | cdnE {ECO:0000303|PubMed:32877915} | c-di-GMP synthase {ECO:0000303|PubMed:32877915}; 2.7.7.65 {ECO:0000269|PubMed:32877915}; FsCdnE {ECO:0000303|PubMed:32877915}; cGAS/DncV-like nucleotidyltransferase; CD-NTase | 0 |
60130 | CDNE_ELIME | P0DSP2 | cdnE01 {ECO:0000303|PubMed:30787435} | Cyclic dipurine nucleotide synthase {ECO:0000305|PubMed:30787435}; 2.7.7.- {ECO:0000269|PubMed:30787435}; Cyclic GMP-AMP synthase {ECO:0000305|PubMed:30787435}; cGAMP synthase {ECO:0000305|PubMed:30787435}; c-di-AMP synthase {ECO:0000305|PubMed:30787435}; 2.7.7.85 {ECO:0000269|PubMed:30787435}; c-di-GMP synthase {ECO:0000305|PubMed:30787435}; 2.7.7.65 {ECO:0000269|PubMed:30787435}; cGAS/DncV-like nucleotidyltransferase {ECO:0000303|PubMed:30787435}; CD-NTase {ECO:0000303|PubMed:30787435} | 0 |
60129 | CDNE_ECOLX | Q6XGD5 | cdnE {ECO:0000303|PubMed:30787435} | Cyclic UMP-AMP synthase {ECO:0000303|PubMed:30787435}; cUMP-AMP synthase {ECO:0000303|PubMed:30787435}; 2.7.7.- {ECO:0000269|PubMed:30787435}; 3',3'-cUAMP synthase {ECO:0000305|PubMed:30787435}; cGAS/DncV-like nucleotidyltransferase in E.coli {ECO:0000303|PubMed:30787435}; CD-NTase056 {ECO:0000303|PubMed:30787435} | 0 |
60128 | CDNE_CAPGB | A0A381HBN1 | cdnE | c-di-GMP synthase {ECO:0000303|PubMed:32877915}; 2.7.7.65 {ECO:0000269|PubMed:32877915}; CgCdnE {ECO:0000303|PubMed:32877915}; cGAS/DncV-like nucleotidyltransferase; CD-NTase | 0 |
60127 | CDNE2_LEGPN | P0DSP3 | cdnE02 {ECO:0000303|PubMed:30787435} | Cyclic dipyrimidine nucleotide synthase {ECO:0000305|PubMed:30787435}; 2.7.7.- {ECO:0000269|PubMed:30787435}; Cyclic CMP-UMP synthase {ECO:0000305|PubMed:30787435}; c-di-UMP synthase {ECO:0000305|PubMed:30787435}; cGAS/DncV-like nucleotidyltransferase {ECO:0000303|PubMed:30787435}; CD-NTase057 {ECO:0000303|PubMed:30787435} | 0 |
60126 | CDND_PSEAI | P0DTF7 | cdnD {ECO:0000303|PubMed:30787435} | Cyclic AMP-AMP-AMP synthase {ECO:0000303|PubMed:31932165}; 2.7.7.- {ECO:0000305|PubMed:31932165}; CD-NTase023 {ECO:0000303|PubMed:30787435}; Cyclic AMP-AMP-GMP synthase {ECO:0000305|PubMed:30787435}; 2.7.7.- {ECO:0000269|PubMed:30787435}; c-di-AMP synthase {ECO:0000305|PubMed:31932165}; 2.7.7.85 {ECO:0000269|PubMed:31932165} | 0 |
60125 | CDND_BACCX | R8NBN0 | cdnD {ECO:0000303|PubMed:30787435} | Probable cyclic nucleotide synthase IK1_05630 {ECO:0000305}; 2.7.7.- {ECO:0000305} | 0 |
60124 | CDND_ACIS2 | C0VHD2 | cdnD01 {ECO:0000303|PubMed:30787435} | Cyclic AMP-AMP-AMP synthase {ECO:0000303|PubMed:32544385}; 2.7.7.- {ECO:0000305|PubMed:32544385}; CD-NTase037 {ECO:0000303|PubMed:30787435} | 0 |
60123 | CDND2_ENTCL | P0DSP4 | cdnD02 {ECO:0000303|PubMed:30787435} | Cyclic AMP-AMP-GMP synthase {ECO:0000305|PubMed:30787435}; 2.7.7.- {ECO:0000269|PubMed:30787435}; cGAS/DncV-like nucleotidyltransferase {ECO:0000303|PubMed:30787435}; CD-NTase038 {ECO:0000303|PubMed:30787435} | 0 |
60122 | CDNC_ECOM1 | D7Y2H2 | cdnC {ECO:0000303|PubMed:30787435} | Cyclic AMP-AMP-AMP synthase {ECO:0000303|PubMed:31932165}; 2.7.7.- {ECO:0000305|PubMed:31932165}; CD-NTase018 {ECO:0000303|PubMed:30787435}; c-di-AMP synthase {ECO:0000305|PubMed:31932165}; 2.7.7.85 {ECO:0000269|PubMed:31932165} | 0 |
60121 | CDN71_LITEW | P82051 | | Caeridin-7.1 | 0 |
60120 | CDN6_RANCA | P82078 | | Caeridin-6 | 0 |
60119 | CDN5_RANCA | P82077 | | Caeridin-5 | 0 |
60118 | CDN4_RANCA | P82076 | | Caeridin-4 | 0 |
60117 | CDN3_RANGI | P56248 | | Caeridin-3 | 0 |
60116 | CDN2_RANGI | P56247 | | Caeridin-2 | 0 |
60115 | CDN2D_MOUSE | Q60773; Q60794; Q91YV3 | Cdkn2d | Cyclin-dependent kinase 4 inhibitor D; p19-INK4d | 12581 |
60114 | CDN2D_HUMAN | P55273; Q13102; Q6FGE9 | CDKN2D | Cyclin-dependent kinase 4 inhibitor D; p19-INK4d | 1032 |
60113 | CDN2D_BOVIN | Q29RV0 | CDKN2D | Cyclin-dependent kinase 4 inhibitor D; p19-INK4d | 510244 |
60112 | CDN2C_MOUSE | Q60772 | Cdkn2c | Cyclin-dependent kinase 4 inhibitor C; Cyclin-dependent kinase 6 inhibitor; p18-INK4c; p18-INK6 | 12580 |
60111 | CDN2C_HUMAN | P42773; Q8TB83 | CDKN2C | Cyclin-dependent kinase 4 inhibitor C; Cyclin-dependent kinase 6 inhibitor; p18-INK4c; p18-INK6 | 1031 |
60110 | CDN2B_RAT | P55272 | Cdkn2b | Cyclin-dependent kinase 4 inhibitor B; p14-INK4b; p15-INK4b | 25164 |
60109 | CDN2B_MOUSE | P55271 | Cdkn2b | Cyclin-dependent kinase 4 inhibitor B; p14-INK4b; p15-INK4b | 12579 |
60108 | CDN2B_HUMAN | O15125; P42772; Q6FI09 | CDKN2B | Cyclin-dependent kinase 4 inhibitor B; Multiple tumor suppressor 2; MTS-2; p14-INK4b; p15-INK4b; p15INK4B | 1030 |
60107 | CDN2B_BOVIN | Q2KJD8 | CDKN2B | Cyclin-dependent kinase 4 inhibitor B; p14-INK4b | 527124 |
60106 | CDN2A_RAT | Q9R0Z3 | Cdkn2a {ECO:0000312|EMBL:AAL76338.1, ECO:0000312|RGD:2323} | Cyclin-dependent kinase inhibitor 2A {ECO:0000312|RGD:2323}; Cyclin-dependent kinase 4 inhibitor A; CDK4I; p16-INK4a; p16; p16-INK4 | 25163 |
60105 | CDN2A_MOUSE | A2ANM1; A2ANM2; O89088; P51480; P97510; P97937; Q6PEA2; Q78E39; Q78E57 | Cdkn2a {ECO:0000312|MGI:MGI:104738} | Cyclin-dependent kinase inhibitor 2A {ECO:0000312|MGI:MGI:104738}; Cyclin-dependent kinase 4 inhibitor A; CDK4I; p16-INK4a; p16-INK4 | 12578 |
60104 | CDN2A_MONDO | O77617; Q548V3 | CDKN2A {ECO:0000303|PubMed:9839807} | Cyclin-dependent kinase inhibitor 2A {ECO:0000305|PubMed:9839807}; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Tumor suppressor CDKN2A; p16-INK4a; p16-INK4 | 554242 |
60103 | CDN2A_HUMAN | A5X2G7; D3DRK1; G3XAG3; O95440; P42771; Q15191; Q5VVJ5; Q96B52; Q9NP05 | CDKN2A {ECO:0000312|HGNC:HGNC:1787} | Cyclin-dependent kinase inhibitor 2A {ECO:0000312|HGNC:HGNC:1787}; Cyclin-dependent kinase 4 inhibitor A; CDK4I; Multiple tumor suppressor 1; MTS-1; p16-INK4a; p16-INK4; p16INK4A | 1029 |